Loading...
Market
Change in Rite Aid's market cap by end of 2024
4
Resolution / Starting Odds
Increase by more than 20% • 25%
Increase by 0-20% • 25%
Decrease by 0-20% • 25%
Decrease by more than 20% • 25%
Market capitalization data from financial information services such as Yahoo Finance or Bloomberg
Story
Rite Aid Wins $200 Million Dispute Over Elixir Sale After Judge's Monday Ruling
Jun 24, 2024, 06:00 PM
Rite Aid has successfully defeated MedImpact Healthcare Systems in a $200 million dispute over the sale of its pharmacy benefit manager, Elixir. A judge ruled on Monday that MedImpact is not entitled to recoup the $200 million in extra costs, as it assumed Elixir's debts when it acquired the company. This ruling absolves Rite Aid of any responsibility for the additional costs tied to the recent acquisition.
View original story
Similar markets
Increase by > 5% • 25%
Increase by ≤ 5% • 25%
Decrease by ≤ 5% • 25%
Decrease by > 5% • 25%
Net Profit • 25%
Net Loss < $100 Million • 25%
Net Loss $100-$500 Million • 25%
Net Loss > $500 Million • 25%
CEO Resigns • 25%
CFO Resigns • 25%
Both CEO and CFO Resign • 25%
No Changes • 25%
Market cap increases by over 10% • 25%
Market cap increases by 0-10% • 25%
Market cap decreases by 0-10% • 25%
Market cap decreases by over 10% • 25%
Less than $150 billion • 25%
$150 billion to $170 billion • 25%
$170 billion to $190 billion • 25%
More than $190 billion • 25%
Increase by more than 10% • 25%
Increase by 0-10% • 25%
Decrease by 0-10% • 25%
Decrease by more than 10% • 25%
Increase by more than 10% • 25%
Increase by 0-10% • 25%
Decrease by 0-10% • 25%
Decrease by more than 10% • 25%
Pfizer • 33%
Johnson & Johnson • 33%
Eli Lilly • 33%
Below $5 billion • 25%
$5 billion to $10 billion • 25%
$10 billion to $15 billion • 25%
Above $15 billion • 25%